Zimmer's smaller units shine in "acceptable" Q2
This article was originally published in Clinica
Executive Summary
Zimmer's 15% second-quarter sales increase, to $847m, was driven by solid growth in its biggest segments, while its smaller business activities, dental and spine, turned in particularly robust performances. Group net income rose by 64% to $191m. Spinal sales were up by 22% to $41m, while dental revenues rose by 28% to $40m. As Merrill Lynch analyst Michael Jungling noted, Zimmer Dental is the fourth-largest dental implant business with a worldwide market share of around 10%. He said it was one of the faster growing businesses. Meanwhile, Zimmer's main businesses of hip and knee products grew by 20% (to $354m) and 10% (to $294m), respectively, driven by its focus on minimally-invasive techniques.